Case File
efta-efta00962718DOJ Data Set 9OtherFrom: "McCaffrey, Carlyn"
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00962718
Pages
4
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "McCaffrey, Carlyn"
To: Jeffrey Epstein <[email protected]>
Subject: RE: FW: Shelf GRATs
Date: Thu, 13 Jun 2013 19:59:51 +0000
>
Sure
Carlyn S. McCaffrey I Partner
McDermott Will & Emery LLP I 340 Madison Avenue, New York, NY 10173
From: Jeffrey Epstein [[email protected]]
Sent: Thursday, June 13, 2013 12:42 PM
To: McCaffrey, Carlyn
Subject: Re: FW: Shelf GRATs great . swaps as well??
On Thu, Jun 13, 2013 at 6:04 PM, McCaffrey, Carlyn <
> wrote:
Options are generally good candidates for GRAT funding with one caveat. Someone has registered a patent on using
options to fund a GRAT. So the options should probably be put in an LLC before the transfer is made to a GRAT.
Carlyn S. McCaffrey I Partner
McDermott Will & Emery LLP 1340 Madison Avenue, New York, NY 10173
From: Jeffrey Epstein [maifo:[email protected]
Sent: Thursday, June 13, 2013 11:59 AM
To: McCaffrey, Carlyn
Subject: Re: FW: Shelf GRATs very clever. wondering if somehow options could leverage the benefit
On Thu, Jun 13, 2013 at 4:21 PM, McCaffrey, Carlyn <
> wrote:
Dear Jeffrey,
I thought you might be interested in seeing this email we recently shared with the family office of one of our
clients.
Best,
Carlyn
Carlyn S. McCaffrey I Partner
McDermott Will & Emery LLP 1340 Madison Avenue, New York, NY 10173
From: McCaffrey, Carlyn
Sent: Sunday, June 09, 2013 4:23 PM
To:
EFTA00962718
Cc: Kirschner, Elyse
Subject: Shelf GRATs
Dear [Head of Family Office],
In view of [Client's] concern that interest rates will begin rising soon and that GRATs will, therefore, be less
desirable, I thought you might like to read about Shelf GRATs. Here are links to two articles that discuss them.
http://www.americanbar.org/publications/probate_property magazine_2012/2013/mayjune_2013/article_parthe
mer_shelf_grats.html http://www.ustrust.corn/Publish/Content/application/pdf/GWMOL/Shelf GRATs.pdf
A shelf GRAT is a GRAT that's structured for a longer term than ultimately desired and funded with cash or
other safe, low-volatile assets. At some future time the grantor expects to transfer an asset that he believes will
appreciate substantially in exchange for the GRAT's conservative investment. Alternatively, he may anticipate
that the GRAT will have an opportunity in the future to make such an investment.
Suppose, for example, that [Client] thought that in another two years, he was going to have the opportunity to
purchase asset X for $50 million. X is a speculative investment that [Client] hopes will double in value but he
recognizes that it might not be successful. He wants to provide funds to the existing children's trusts to enable
them to participate in the investment. He doesn't want to wait two years to provide the financing because he
thinks interest rates will be at 6% in 2 years.
He could make a 9 year loan of $50 million to the trusts at a current rate of .95% with the expectation that the
trustees would invest the funds conservatively until the time came for them to invest in asset X.
The problem with this approach is that if the trusts use the $50 million to make the investment and the
investment is a failure, they will owe [Client] $50 million and will have little if anything to show for it.
As we have discussed, the GRAT is the vehicle of choice to use for investments when there is a significant risk
of loss. But [Client] doesn't want to wait two years to fund a GRAT, because he thinks the hurdle rate will then
be 6%.
The shelf GRAT approach is a solution. [Client] would fund a 5 year GRAT with $75 million. The GRAT would
be required to make the following payments to him:
1 $ 10,489,131.15
2 $ 12,586,957.38
3 $ 15,104,348.86
4 $ 18,125,218.63
5 $ 21,750,262.35
The present value of this stream of payments is about $75 million
The trustees would invest in a conservative way. At the end of year 2, the GRAT trustees would have about $50
million to make the planned for investment. With the first two years of payments out of the way, the shelf GRAT
is effectively a three year GRAT with a hurdle rate that reflects the low current rate of return.
If the anticipated investment never materializes, nothing has been lost. The assets in the shelf GRAT will return
to [Client] and the GRAT will end at the end of the 5 year period.
Please let us know if you'd like to discuss this further.
Best,
EFTA00962719
Carlyn
Carlyn S. McCaffrey I Partner
McDermott Will & Emery LLP i 340 Madison Avenue. New York, NY 10173
IRS Circular 230 Disclosure: To comply with requirements imposed by the IRS, we inform you that any
U.S. federal tax advice contained herein (including any attachments), unless specifically stated
otherwise, is not intended or written to be used, and cannot be used, for the purposes of (i) avoiding
penalties under the Internal Revenue Code or (ii) promoting, marketing or recommending to another
party any transaction or matter herein.
This message is a PRIVILEGED AND CONFIDENTIAL communication. This message and all
attachments are a private communication sent by a law firm and may be confidential or protected by
privilege. If you are not the intended recipient, you are hereby notified that any disclosure, copying,
distribution or use of the information contained in or attached to this message is strictly prohibited.
Please notify the sender of the delivery error by replying to this message, and then delete it from your
system. Thank you.
Please visit http://www.mwe.com/ for more information about our Firm.
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
EFTA00962720
and may be unlawful. If you have received this communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00962721
Technical Artifacts (6)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Email
[email protected]URL
http://www.americanbar.org/publications/probate_propertyURL
http://www.mwe.comURL
http://www.ustrust.corn/Publish/Content/application/pdf/GWMOL/ShelfRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.